Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ARYx Therapeutics
company
About
ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Close
ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$85.40M
ARYx Therapeutics has raised a total of
$85.40M
in funding over 2 rounds. Their latest funding was raised on
Feb 10, 2006 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 10, 2006 | Series E | $30.40M | 1 | — | — | Detail |
| Jun 1, 2004 | Series D | $55M | 3 |
Phase4 Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
ARYx Therapeutics is funded by 3 investors.
Phase4 Ventures
and Novel Bioventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Phase4 Ventures
|
— | Series E |
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
